arctiin has been researched along with Diabetic Nephropathies in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 4 (66.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, Q; Yang, M; Zuo, Z | 1 |
| Deng, JJ; Liu, DL; Liu, RB; Ma, ST; Niu, R | 1 |
| Chen, YP; Wang, HY | 1 |
| Azeloglu, EU; Chen, Y; Das, B; Deng, Y; He, JC; Lee, K; Li, X; Liu, R; Ma, Y; Muwonge, AN; Wang, T; Wei, C; Wong, NJ; Yang, S; Zhang, W; Zhong, Y | 1 |
| Cao, P; Gui, J; Han, J; Wang, G; Wang, X; Wang, Y; Zhang, J | 1 |
| Chen, YP; Wang, WW | 1 |
1 review(s) available for arctiin and Diabetic Nephropathies
| Article | Year |
|---|---|
Overview of the anti-inflammatory effects, pharmacokinetic properties and clinical efficacies of arctigenin and arctiin from Arctium lappa L.
Topics: Animals; Anti-Infective Agents; Anti-Inflammatory Agents, Non-Steroidal; Antineoplastic Agents; Arctium; Cell Line, Tumor; Diabetic Nephropathies; Furans; Glucosides; Humans; Lignans; Neuroprotective Agents; Pancreatic Neoplasms | 2018 |
1 trial(s) available for arctiin and Diabetic Nephropathies
| Article | Year |
|---|---|
[Clinical observation on treatment of diabetic nephropathy with compound fructus arctii mixture].
Topics: Adult; Albuminuria; Astragalus propinquus; Diabetic Nephropathies; Drug Therapy, Combination; Drugs, Chinese Herbal; Female; Furans; Glucosides; Humans; Losartan; Male; Middle Aged; Phytotherapy | 2004 |
4 other study(ies) available for arctiin and Diabetic Nephropathies
| Article | Year |
|---|---|
Effect of arctiin on glomerular filtration barrier damage in STZ-induced diabetic nephropathy rats.
Topics: Albuminuria; Animals; Blood Glucose; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Furans; Gene Expression Regulation; Glomerular Filtration Barrier; Glucosides; Glucuronidase; Intracellular Signaling Peptides and Proteins; Kidney Glomerulus; Male; Membrane Proteins; Metabolome; Rats; Rats, Sprague-Dawley; RNA, Messenger; Streptozocin | 2013 |
Arctigenin attenuates diabetic kidney disease through the activation of PP2A in podocytes.
Topics: Animals; Arctium; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Disease Progression; Furans; Humans; Lignans; Male; Mice; Mice, Knockout; Microscopy, Electron, Transmission; Nitric Oxide Synthase Type III; Podocytes; Protein Phosphatase 2; Streptozocin; Treatment Outcome | 2019 |
Arctigenin ameliorates renal impairment and inhibits endoplasmic reticulum stress in diabetic db/db mice.
Topics: Animals; Apoptosis; Arctium; Cell Culture Techniques; Cell Line; Diabetes Mellitus, Experimental; Diabetic Nephropathies; Endoplasmic Reticulum Stress; Epithelial Cells; Furans; Humans; Hypoglycemic Agents; Kidney; Lignans; Male; Mice, Inbred C57BL | 2019 |
[Effect of Astragalus and Arctium in different combinations on reactive oxygen species content and nuclear transcription factor kappaB expression in renal tissue of streptozotocin rats].
Topics: Animals; Arctium; Astragalus Plant; Diabetic Nephropathies; Disease Models, Animal; Drug Therapy, Combination; Gene Expression; Humans; NF-kappa B; Plant Extracts; Random Allocation; Rats; Rats, Wistar; Reactive Oxygen Species; Streptozocin | 2008 |